CA
PYXS icon

Cetera Advisors’s Pyxis Oncology PYXS Stock Holding History

Cetera Advisors’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$100K Buy
+23,500
New +$98.8K ﹤0.01% 2307

Other funds holding PYXS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Cetera Advisors's PYXS Position: Q1 2024 in Review

Cetera Advisors opened a new position in Pyxis Oncology (PYXS) in Q1 2024: 23,500 shares worth $100K. The stake represents ﹤0.01% of the portfolio and ranks #2307 among its holdings.

72 funds tracked by Wall St. Rank hold PYXS as of Q1 2024.

  • Cetera Advisors held 23,500 shares of Pyxis Oncology worth $100K as of Q1 2024.
  • Pyxis Oncology was a new Cetera Advisors position in Q1 2024.
  • Pyxis Oncology made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2307 holding.
  • 72 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.